biotech

3 Long Shots Biotech Companies Are Working On
Motley Fool
Sat, 07/11/15 - 10:27 am
biotech
Alzheimer's disease
Parkinson's Disease
Axovant Sciences
RVT 101
GSK
Biogen
aducanumab
Prothena
PRX-002
Volatile Mixture: Young Biotechs' Stock Market Rollercoaster
Forbes
Fri, 07/10/15 - 12:34 pm
biotech
IPOs
startups
Are Biotechs In A Bubble?
Seeking Alpha
Wed, 07/8/15 - 09:31 am
biotech
3 Biotech Stocks That Could Grow Faster than Apple
Motley Fool
Sun, 07/5/15 - 11:00 am
biotech
Celgene
Medivation
Ligand Pharmaceuticals
[video]Should The Biotech Bubble Be Feared?
Bloomberg
Wed, 07/1/15 - 10:53 pm
biotech
The Biotech Drug Lord: How One Man Is Conquering The Biotech Space
Motley Fool
Sun, 06/28/15 - 11:47 am
biotech
OPKO Health
London mayor suggests $15 bln 'megafund' to boost biotech
Yahoo/Reuters
Thu, 06/25/15 - 09:00 am
London
biotech
Biotech's IPO boom flirts with new heights as dollars pour in
Fierce Biotech
Tue, 06/23/15 - 11:05 am
biotech
IPOs
Chris Viehbacher leaps back into biotech as head of Swiss billionaire's $2B fund
Fierce Biotech
Tue, 06/23/15 - 10:31 am
biotech
Chris Viehbacher
Biotechs line up for a busy week of IPOs
Fierce Biotech
Mon, 06/22/15 - 11:17 am
biotech
IPOs
Seres Therapeutics
Glaukos
Pieris
Catabasis
Space in Juno's new Seattle building - get it while it's hot
Bizjournals.com
Wed, 06/17/15 - 06:34 pm
Juno Therapeutics
Seattle
biotech
Good news for drug reps: Pay is growing again. Bad? Biotech outclasses pharma by 36%
Fierce Pharma Marketing
Wed, 06/17/15 - 10:14 am
drug reps
salaries
biotech
Biotech payrolls boom along with sales, while Big Pharma jobs keep disappearing
Fierce Pharma
Mon, 06/15/15 - 04:18 pm
biotech
Big Pharma
jobs
Avalon, GlaxoSmithKline launch 3 new biotechs with $30M commitment
Fierce Biotech
Mon, 06/15/15 - 09:16 am
Avalon Ventures
GSK
biotech
Adrenergics
CadheRx Therapeutics
Calporta Therapeutics
What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play
Forbes
Sat, 06/13/15 - 10:36 am
biotech
GSK
Axovant Sciences
Alzheimer's disease
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Repatha
Amgen
A Drug for Dogs Does Not a Biotech Make Is AB Science Lesson
Bloomberg
Fri, 06/12/15 - 09:35 am
biotech
AB Science
masitinib
R&D
The 29 Year Old Behind The Giant Biotech IPO That Rose By 90% Speaks
Forbes
Thu, 06/11/15 - 06:11 pm
biotech
IPOs
Axovant Sciences
Biotech Boom Cranks Out Some of the Highest-Paid CEOs in America
Bloomberg
Thu, 06/11/15 - 10:59 am
biotech
executive pay
Is There a Biotech Bubble?
FOX Business
Thu, 06/11/15 - 10:06 am
biotech
Bioheart CEO Tomas Voted Top Entrepreneur
Yahoo
Mon, 06/8/15 - 10:44 am
Bioheart
biotech
Mike Tomas

Pages